glycoprotein IIb/IIIa

Related Overviews


'glycoprotein IIb/IIIa' can also refer to...

glycoprotein IIb/IIIa

Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease

A cold start for oral glycoprotein IIb/IIIa antagonists

Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?

Platelet glycoprotein IIb/IIIa receptor inhibitors—end of an era?

Effect of the Glycoprotein IIb/IIIa Inhibitor Tirofiban on Concentrations of Whole Blood Choline in Acute Coronary Syndromes

More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials

Paradoxical inhibition of fibrinogen binding and potentiation of α-granule release by specific types of inhibitors of glycoprotein IIb–IIIa

Simultaneous integrin αvβ3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

Non-ST-elevation acute coronary syndromes management: a fresh look at glycoprotein IIb/IIIa inhibitors

153 Left ventricle mural thrombus early after acute myocardial infarction in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors

Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass


More Like This

Show all results sharing this subject:

  • Chemistry


Show Summary Details

Quick Reference

abbr.: GpIIb/IIIa; a major glycoprotein complex of the platelet surface. GpIIb consists of a heavy chain (containing seven homologous repeats that form a beta propeller and including four Ca2+‐binding sites) ...

Subjects: Chemistry.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.